| 000 | 01864 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250514005752.0 | ||
| 264 | 0 | _c20011004 | |
| 008 | 200110s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 024 | 7 |
_a10.1182/blood.v98.5.1346 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoodnough, L T | |
| 245 | 0 | 0 |
_aProphylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. _h[electronic resource] |
| 260 |
_bBlood _cSep 2001 |
||
| 300 |
_a1346-51 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aBlood Donors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemorrhage _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xblood |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aPlatelet Transfusion _xadverse effects |
| 650 | 0 | 4 | _aPlateletpheresis |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadministration & dosage |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 650 | 0 | 4 |
_aThrombopoietin _xadministration & dosage |
| 700 | 1 | _aKuter, D J | |
| 700 | 1 | _aMcCullough, J | |
| 700 | 1 | _aSlichter, S J | |
| 700 | 1 | _aDiPersio, J | |
| 700 | 1 | _aRomo, J | |
| 700 | 1 | _aPeterson, R | |
| 700 | 1 | _aSmith, K J | |
| 700 | 1 | _aRaife, T | |
| 700 | 1 | _aTomita, D | |
| 700 | 1 | _aArmstrong, S | |
| 773 | 0 |
_tBlood _gvol. 98 _gno. 5 _gp. 1346-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.v98.5.1346 _zAvailable from publisher's website |
| 999 |
_c11445106 _d11445106 |
||